Rhythm Pharmaceuticals ( RYTM +2.09%) is another biotech stock (in this case, a mid-cap stock) that I think could easily ...

Despite its fourth-quarter results being pretty solid, the share price of pharmaceutical giant AbbVie ( ABBV +1.71%) fell ...

His most recent AI stock purchase is already up 1,650% since its IPO, but Ackman sees plenty of room for the stock to keep climbing. In the meantime, he fully exited a stock Pershing Square has held ...

The energy company tumbled over the past month as regulators discussed emergency auctions and capacity-market price collars in one of its key markets.

Many analysts expect Kevin Warsh, who could become the next Fed chair this May, to continue cutting rates to spur fresh ...

Silver surged by a whopping 144% during 2025, partly because investors piled into precious metals to hedge against rising ...

That's one of the reasons why there's still time to invest in the Invesco QQQ Trust. This trend of rising passive fund flows ...

Duolingo's daily and monthly user metrics reached a new inflection point in 2025. The platform broke past 50 million daily ...

These companies should benefit from a normalization of the healthcare market in 2026, making them cheap buys today.

Coca-Cola ( KO 0.41%) is older than clothing zippers, airplanes, and sliced bread. The company, now 134 years old, continues to dominate the beverage space and remain relevant worldwide. There are ...

An investment of $1,000 in this semiconductor stock three years ago is now worth just under $8,601. Nvidia stock is now ...

Goldman Sachs expects European and emerging-market equities to beat the U.S. stock market over the next decade.